ArriVent BioPharma, Inc. (AVBP)

ArriVent BioPharma Statistics

Total Valuation

AVBP has a market cap or net worth of $1.30 billion. The enterprise value is $972.08 million.

Market Cap	1.30B
Enterprise Value	972.08M

Important Dates

The last earnings date was Monday, May 11, 2026, after market close.

Earnings Date	May 11, 2026
Ex-Dividend Date	n/a

Share Statistics

AVBP has 46.57 million shares outstanding. The number of shares has increased by 22.48% in one year.

Current Share Class	46.57M
Shares Outstanding	46.57M
Shares Change (YoY)	+22.48%
Shares Change (QoQ)	+4.95%
Owned by Insiders (%)	1.93%
Owned by Institutions (%)	65.68%
Float	29.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.90
P/TBV Ratio	4.01
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.95, with a Debt / Equity ratio of 0.00.

Current Ratio	13.95
Quick Ratio	13.06
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -55.17% and return on invested capital (ROIC) is -37.20%.

Return on Equity (ROE)	-55.17%
Return on Assets (ROA)	-34.72%
Return on Invested Capital (ROIC)	-37.20%
Return on Capital Employed (ROCE)	-48.37%
Weighted Average Cost of Capital (WACC)	12.62%
Revenue Per Employee	n/a
Profits Per Employee	-$1.89M
Employee Count	77
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +48.80% in the last 52 weeks. The beta is 1.52, so AVBP's price volatility has been higher than the market average.

Beta (5Y)	1.52
52-Week Price Change	+48.80%
50-Day Moving Average	26.69
200-Day Moving Average	22.19
Relative Strength Index (RSI)	44.92
Average Volume (20 Days)	419,952

Short Selling Information

The latest short interest is 7.11 million, so 15.27% of the outstanding shares have been sold short.

Short Interest	7.11M
Short Previous Month	7.67M
Short % of Shares Out	15.27%
Short % of Float	23.88%
Short Ratio (days to cover)	13.97

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-156.87M
Pretax Income	-145.24M
Net Income	-145.24M
EBITDA	n/a
EBIT	-156.87M
Earnings Per Share (EPS)	-$3.52

Balance Sheet

The company has $326.38 million in cash and $419,000 in debt, with a net cash position of $325.96 million or $7.00 per share.

Cash & Cash Equivalents	326.38M
Total Debt	419,000
Net Cash	325.96M
Net Cash Per Share	$7.00
Equity (Book Value)	323.98M
Book Value Per Share	7.15
Working Capital	323.71M

Cash Flow

Operating Cash Flow	-134.47M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVBP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.48%
Shareholder Yield	-22.48%
Earnings Yield	-11.19%
FCF Yield	n/a

Analyst Forecast

The average price target for AVBP is $42.00, which is 50.54% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$42.00
Price Target Difference	50.54%
Analyst Consensus	Strong Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1